Sita Awasthi

9PUBLICATIONS
17CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsFoetal development and medicineGenetically modified animalsNanotoxicology, health and safetyGenetically modified horticulture plants
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 27, 2026
Immunogenicity and Efficacy of a Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Against HSV-1 Eye Infection and Neuroinvasion in Mice.

Alyssa Chalmin Katz, Kevin P Egan, Zauraiz Syeda

|Jun 27, 2025
Seroconversion Is Misleading as a Test for HSV-2 Infection in Prophylactic Genital Herpes Vaccine Trials: Results of Vaccine Studies in Guinea Pigs.

Valerie Bromberg, Lauren M Hook, John M Lubinski

|Jul 29, 2023
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1.

Kevin P Egan, Sita Awasthi, Giulia Tebaldi

|May 27, 2023
Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs.

Sita Awasthi, Motoyasu Onishi, John M Lubinski

|Mar 26, 2022
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine.

Lauren M Hook, Sita Awasthi, Tina M Cairns

|Jul 28, 2020
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection.

Kevin P Egan, Lauren M Hook, Alexis Naughton

Pageof 2

Frequent Collaborators

8 joint publications

Harvey M Friedman

7 joint publications

Lauren M Hook

3 joint publications

Kevin P Egan

2 joint publications

Gary H Cohen